Submitted:
22 February 2026
Posted:
25 February 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design and Implementation Considerations
2.2. Participants
2.3. Intervention
2.4. Primary Assessment Measures and Data Collection
2.5. Secondary Assessment Measure and Data Collection
2.6. Data Analysis
2.6.1. Workplace Self-Efficacy Survey Statistical Analysis
2.6.2. Interview Data Analysis
2.6.3. IQ Score Data Analysis
2.7. Ethics
3. Results
3.1. Participant Characteristics
3.2. Primary Outcome: Workplace Self-Efficacy Survey Results
3.2.1. Workplace Self-Efficacy Score
3.2.2. Work Performance Rating
3.2.3. Cognitive Performance Rating
3.2.4. Home Functioning Rating
3.3. Primary Outcome: Interview Results
3.3.1. Executive Function
3.3.2. Productivity
3.3.3. Health and Energy
3.3.4. Daily Living Activities
3.3.5. Socioemotional Functioning
3.3.5. Work and School Cross-Case Synthesis
3.4. Secondary Outcome: IQ Score Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| ADLs | Activities of Daily Living |
| IADLs | Instrumental Activities of Daily Living |
| WJIV | Woodcock Johnson IV Tests of Cognitive Abilities |
| GIA | General Intellectual Ability |
| IQ | Intelligence Quotient |
| WSES | Workplace Self-Efficacy Survey |
Appendix A
Appendix A.1. Questions on Workplace Self-Efficacy Surveys
References
- Nalbandian, A.; Sehgal, K.; Gupta, A.; Madhavan, M.V.; McGroder, C.; Stevens, J.S.; Cook, J.R.; Nordvig, A.S.; Shalev, D.; Sehrawat, T.S.; et al. Post-Acute COVID-19 Syndrome. Nat. Med. 2021, 27, 601–615. [Google Scholar] [CrossRef]
- Davis, H.E.; McCorkell, L.; Vogel, J.M.; Topol, E.J. Long COVID: Major Findings, Mechanisms and Recommendations. Nat. Rev. Microbiol. 2023, 21, 133–146. [Google Scholar] [CrossRef] [PubMed]
- Proal, A.D.; VanElzakker, M.B. Long COVID or Post-Acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021, 12, 698169. [Google Scholar] [CrossRef]
- Choutka, J.; Jansari, V.; Hornig, M.; Iwasaki, A. Unexplained Post-Acute Infection Syndromes. Nat. Med. 2022, 28, 911–923. [Google Scholar] [CrossRef]
- Meinhardt, J.; Radke, J.; Dittmayer, C.; Franz, J.; Thomas, C.; Mothes, R.; Laue, M.; Schneider, J.; Brünink, S.; Greuel, S.; et al. Olfactory Transmucosal SARS-CoV-2 Invasion as a Port of Central Nervous System Entry in Individuals with COVID-19. Nat. Neurosci. 2021, 24, 168–175. [Google Scholar] [CrossRef]
- Greene, C.; Connolly, R.; Brennan, D.; Laffan, A.; O’Keeffe, E.; Zaporojan, L.; O’Callaghan, J.; Thomson, B.; Connolly, E.; Argue, R.; et al. Blood–Brain Barrier Disruption and Sustained Systemic Inflammation in Individuals with Long COVID-Associated Cognitive Impairment. Nat. Neurosci. 2024, 27, 421–432. [Google Scholar] [CrossRef] [PubMed]
- Andrews, M.G.; Mukhtar, T.; Eze, U.C.; Simoneau, C.R.; Ross, J.; Parikshak, N.; Wang, S.; Zhou, L.; Koontz, M.; Velmeshev, D.; et al. Tropism of SARS-CoV-2 for Human Cortical Astrocytes. Proc. Natl. Acad. Sci. 2022, 119, e2122236119. [Google Scholar] [CrossRef] [PubMed]
- Crunfli, F.; Carregari, V.C.; Veras, F.P.; Silva, L.S.; Nogueira, M.H.; Antunes, A.S.L.M.; Vendramini, P.H.; Valença, A.G.F.; Brandão-Teles, C.; Zuccoli, G.D.S.; et al. Morphological, Cellular, and Molecular Basis of Brain Infection in COVID-19 Patients. Proc. Natl. Acad. Sci. 2022, 119, e2200960119. [Google Scholar] [CrossRef]
- Huang, S.; Fishell, G. SARS-CoV-2, Astrocytes Are in It for the Long Haul. Proc. Natl. Acad. Sci. 2022, 119, e2209130119. [Google Scholar] [CrossRef]
- Fernández-Castañeda, A.; Lu, P.; Geraghty, A.C.; Song, E.; Lee, M.-H.; Wood, J.; O’Dea, M.R.; Dutton, S.; Shamardani, K.; Nwangwu, K.; et al. Mild Respiratory COVID Can Cause Multi-Lineage Neural Cell and Myelin Dysregulation. Cell 2022, 185, 2452–2468.e16. [Google Scholar] [CrossRef]
- Douaud, G.; Lee, S.; Alfaro-Almagro, F.; Arthofer, C.; Wang, C.; McCarthy, P.; Lange, F.; Andersson, J.L.R.; Griffanti, L.; Duff, E.; et al. SARS-CoV-2 Is Associated with Changes in Brain Structure in UK Biobank. Nature 2022, 604, 697–707. [Google Scholar] [CrossRef]
- Boldrini, M.; Canoll, P.D.; Klein, R.S. How COVID-19 Affects the Brain. JAMA Psychiatry 2021, 78, 682. [Google Scholar] [CrossRef]
- Yong, S.J. Persistent Brainstem Dysfunction in Long-COVID: A Hypothesis. ACS Chem. Neurosci. 2021, 12, 573–580. [Google Scholar] [CrossRef]
- Monje, M.; Iwasaki, A. The Neurobiology of Long COVID. Neuron 2022, 110, 3484–3496. [Google Scholar] [CrossRef]
- Fujimoto, Y.; Abe, H.; Eiro, T.; Tsugawa, S.; Tanaka, M.; Hatano, M.; Nakajima, W.; Ichijo, S.; Arisawa, T.; Takada, Y.; et al. Systemic Increase of AMPA Receptors Associated with Cognitive Impairment of Long COVID. Brain Commun. 2025, 7, fcaf337. [Google Scholar] [CrossRef]
- Davis, H.E.; Assaf, G.S.; McCorkell, L.; Wei, H.; Low, R.J.; Re’em, Y.; Redfield, S.; Austin, J.P.; Akrami, A. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. eClinicalMedicine 2021, 38, 101019. [Google Scholar] [CrossRef]
- Al-Aly, Z.; Xie, Y.; Bowe, B. High-Dimensional Characterization of Post-Acute Sequelae of COVID-19. Nature 2021, 594, 259–264. [Google Scholar] [CrossRef]
- Graham, E.L.; Clark, J.R.; Orban, Z.S.; Lim, P.H.; Szymanski, A.L.; Taylor, C.; DiBiase, R.M.; Jia, D.T.; Balabanov, R.; Ho, S.U.; et al. Persistent Neurologic Symptoms and Cognitive Dysfunction in Non-hospitalized Covid-19 Long Haulers. Ann. Clin. Transl. Neurol. 2021, 8, 1073–1085. [Google Scholar] [CrossRef] [PubMed]
- García-Molina, A.; García-Carmona, S.; Espiña-Bou, M.; Rodríguez-Rajo, P.; Sánchez-Carrión, R.; Enseñat-Cantallops, A. Neuropsychological Rehabilitation for Post–COVID-19 Syndrome: Results of a Clinical Programme and Six-Month Follow Up. Neurol. Engl. Ed. 2024, 39, 592–603. [Google Scholar] [CrossRef]
- Nagra, G.; Ezeugwu, V.E.; Bostick, G.P.; Branton, E.; Dennett, L.; Drake, K.; Durand-Moreau, Q.; Guptill, C.; Hall, M.; Ho, C.; et al. Return-to-Work for People Living with Long COVID: A Scoping Review of Interventions and Recommendations. PLOS One 2025, 20, e0321891. [Google Scholar] [CrossRef] [PubMed]
- Braga, L.W.; Oliveira, S.B.; Moreira, A.S.; Martins Pereira, M.E.M.D.S.; Serio, A.S.S.; Carneiro, V.D.S.; Freitas, L.D.F.P.; Souza, L.M.D.N. Long COVID Neuropsychological Follow-up: Is Cognitive Rehabilitation Relevant? NeuroRehabilitation 2023, 53, 517–534. [Google Scholar] [CrossRef]
- Weix, N.M.; Shake, H.M.; Duran Saavedra, A.F.; Clingan, H.E.; Hernandez, V.C.; Johnson, G.M.; Hansen, A.D.; Collins, D.M.; Pryor, L.E.; Kitchens, R.; et al. Cognitive Interventions and Rehabilitation to Address Long-COVID Symptoms: A Systematic Review. OTJR Occup. Ther. J. Res. 2026, 46, 74–95. [Google Scholar] [CrossRef]
- Uswatte, G.; Taub, E.; Ball, K.; Mitchell, B.S.; Blake, J.A.; McKay, S.; Biney, F.; Iosipchuk, O.; Hempfling, P.; Harris, E.; et al. Long COVID Brain Fog Treatment: An Early-Phase Randomized Controlled Trial of Constraint-Induced Cognitive Therapy Signals Go. Rehabil. Psychol. 2025. [Google Scholar] [CrossRef] [PubMed]
- Bashir, S.; Mizrahi, I.; Weaver, K.; Fregni, F.; Pascual-Leone, A. Assessment and Modulation of Neural Plasticity in Rehabilitation With Transcranial Magnetic Stimulation. PM&R 2010, 2. [Google Scholar] [CrossRef] [PubMed]
- Lampit, A.; Hallock, H.; Valenzuela, M. Computerized Cognitive Training in Cognitively Healthy Older Adults: A Systematic Review and Meta-Analysis of Effect Modifiers. PLoS Med. 2014, 11, e1001756. [Google Scholar] [CrossRef]
- Gavelin, H.M.; Domellöf, M.E.; Leung, I.; Neely, A.S.; Launder, N.H.; Nategh, L.; Finke, C.; Lampit, A. Computerized Cognitive Training in Parkinson’s Disease: A Systematic Review and Meta-Analysis. Ageing Res. Rev. 2022, 80, 101671. [Google Scholar] [CrossRef]
- Ledbetter, C.; Moore, A.L.; Mitchell, T. Cognitive Effects of ThinkRx Cognitive Rehabilitation Training for Eleven Soldiers with Brain Injury: A Retrospective Chart Review. Front. Psychol. 2017, 8, 825. [Google Scholar] [CrossRef]
- Moore, A.L.; Carpenter, D.M.; James, R.L.; Miller, T.M.; Moore, J.J.; Disbrow, E.A.; Ledbetter, C.R. Neuroimaging and Neuropsychological Outcomes Following Clinician-Delivered Cognitive Training for Six Patients With Mild Brain Injury: A Multiple Case Study. Front. Hum. Neurosci. 2020, 14, 229. [Google Scholar] [CrossRef]
- Moore, A.L.; Carpenter, D.M.; Miller, T.M.; Ledbetter, C. ThinkRx Cognitive Training for Adults over Age 50: Clinician–Caregiver Partners in Delivery as Effective as Clinician-Only Delivery. Psychol. Neurosci. 2019, 12, 291–306. [Google Scholar] [CrossRef]
- Moore, A.L.; Miller, T.M.; Ledbetter, C. Remote vs. In-Person Delivery of LearningRx One-on-One Cognitive Training During the COVID-19 Pandemic: A Non-Inferiority Study. Front. Psychol. 2021, 12, 749898. [Google Scholar] [CrossRef] [PubMed]
- James, R.; Lawson Moore, A.; Carpenter, D.M., Ii; Miller, T.M.; Ledbetter, C. Feasibility of a Functional Medicine Approach to Slowing Clinical Cognitive Decline in Patients over Age 55: A Multiple Case Study Report. OBM Integr. Complement. Med. 2019, 04, 1–36. [Google Scholar] [CrossRef]
- Moore, A.L.; Carpenter, D.M., Ii; Miller, T.M.; Ledbetter, C. Clinician-Delivered Cognitive Training for Children with Attention Problems: Effects on Cognition and Behavior from the ThinkRx Randomized Controlled Trial. Neuropsychiatr. Dis. Treat. 2018, Volume 14, 1671–1683. [Google Scholar] [CrossRef]
- Jedlicka, E.J. LearningRx Cognitive Training for Children and Adolescents Ages 5–18: Effects on Academic Skills, Behavior, and Cognition. Front. Educ. 2017, 2, 62. [Google Scholar] [CrossRef]
- Carpenter, D.M.; Ledbetter, C.; Moore, A.L. LearningRx Cognitive Training Effects in Children Ages 8–14: A Randomized Controlled Trial. Appl. Cogn. Psychol. 2016, 30, 815–826. [Google Scholar] [CrossRef]
- Onken, L.S.; Carroll, K.M.; Shoham, V.; Cuthbert, B.N.; Riddle, M. Reenvisioning Clinical Science: Unifying the Discipline to Improve the Public Health. Clin. Psychol. Sci. 2014, 2, 22–34. [Google Scholar] [CrossRef] [PubMed]
- Eldridge, S.M.; Chan, C.L.; Campbell, M.J.; Bond, C.M.; Hopewell, S.; Thabane, L.; Lancaster, G.A. CONSORT 2010 Statement: Extension to Randomised Pilot and Feasibility Trials. BMJ 2016, i5239. [Google Scholar] [CrossRef]
- Harris, P.A.; Taylor, R.; Thielke, R.; Payne, J.; Gonzalez, N.; Conde, J.G. Research Electronic Data Capture (REDCap)—A Metadata-Driven Methodology and Workflow Process for Providing Translational Research Informatics Support. J. Biomed. Inform. 2009, 42, 377–381. [Google Scholar] [CrossRef] [PubMed]
- Harris, P.A.; Taylor, R.; Minor, B.L.; Elliott, V.; Fernandez, M.; O’Neal, L.; McLeod, L.; Delacqua, G.; Delacqua, F.; Kirby, J.; et al. The REDCap Consortium: Building an International Community of Software Platform Partners. J. Biomed. Inform. 2019, 95, 103208. [Google Scholar] [CrossRef]
- Schrank, F.; McGrew, K.; Mather, N. Woodcock–Johnson IV Tests of Cognitive Abilities, 4th ed.; Riverside: Rolling Meadows, IL.
- McGrew, K.; LaForte, E.; Schrank, F. Woodcock–Johnson IV Technical Manual, 4th ed.; Riverside: Rolling Meadows, IL, 2014. [Google Scholar]
- Braun, V.; Clarke, V. Using Thematic Analysis in Psychology. Qual. Res. Psychol. 2006, 3, 77–101. [Google Scholar] [CrossRef]
- Highland, S. Examining the Self-Efficacy Perceptions of Adults Who Completed a ThinkRx One-on-One Brain Training Program. Doctoral dissertation, Grand Canyon University, Phoenix, AZ, 2019. [Google Scholar]


| Training Hours | Number of Sessions | Session Duration (min) | Training Months |
| 45 | 30 | 90 | 4 |
| 45 | 45 | 60 | 5 |
| 60 | 43 | 90 | 7 |
| 60 | 59 | 60 | 6 |
| 75 | 63 | 60/90 | 13 |
| 75 | 64 | 60 | 9 |
| 90 | 60 | 90 | 11 |
| 90 | 90 | 60 | 10 |
| 90 | 90 | 90 | 13 |
| WSES Scores |
Before COVID Mean (SD) |
After COVID (Mean (SD) |
Post Intervention Mean (SD) |
Time Effect Size |
|
Workplace Self-Efficacy Score |
239.55 (4.9) | 119.66 (22.1) | 201.22 (20.6) | .69 |
|
Work Performance Rating |
177.56 (3.2) | 90.89 (16.1) | 147.11 (15.4) | .69 |
|
Cognitive Performance Rating |
62.00 (2.1) | 28.78 (6.3) | 53.11 (5.2) | .69 |
|
Home Functioning Rating |
26.89 (.93) | 13.44 (2.4) | 23.67 (2.5) | .69 |
| Theme | Percent Reporting | Examples of Impact |
| Executive Function | 100% | Attention, memory, processing speed, learning, planning, time management |
| Health and Energy | 100% | Fatigue, sleep, endurance, exercise, autonomic dysfunction |
| Daily Living Activities | 87% | Hygiene, home organization, driving, household choirs, caregiving |
| Productivity | 100% | Work hours, punctuality, performance, workload |
| Socioemotional Functioning | 100% | Confidence, emotion regulation, relationships, distress |
| Work/School Subtheme | Examples |
Percent Reporting Difficulty Pre-Intervention |
Percent Reporting Improvements Post-Intervention |
| Cognitive processing and comprehension difficulties |
Difficulty learning new information, trouble comprehending written material, reduced attention span, slow verbal processing | 100% | 100% |
| Memory problems impacting work or school |
Short-term memory lapses, forgetting tasks or appointments, needing extensive lists, difficulty retaining information | 100% | 88% |
| Executive dysfunction in work/school tasks | Procrastination, difficulty initiating or completing tasks, disorganization, poor time management, impaired planning and prioritizing | 100% | 100% |
| Fatigue limits performance |
Exhaustion, mental & physical fatigue, limited ability to stay at work/school a full day |
75% | 63% |
| Emotional distress and confidence loss in work or academics | Anxiety, depression, distress about decline, loss of confidence in ability, loss of identity at work or school roles | 88% | 88% |
| Work/academic performance impairment and disruption |
Reduced productivity or accuracy, missed deadlines, underperformance, employment loss or fear of loss | 100% | 100% |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).